<DOC>
	<DOCNO>NCT01233843</DOCNO>
	<brief_summary>The purpose study demonstrate induction chemotherapy follow radiation therapy plus Cetuximab give good result validate treatment ( chemoradiotherapy ) , treatment locoregional advanced head neck cancer .</brief_summary>
	<brief_title>Chemoradiotherapy HNSCC , Randomized Study , Docetaxel , Cisplatin , 5FU , Erbitux .</brief_title>
	<detailed_description>Concurrent chemoradiotherapy ( radiotherapy+ carboplatin + 5FU ) validate treatment patient locoregional advanced head neck cancer . This study evaluate outcome induction chemotherapy ( docetaxel , cisplatin , 5 FU ) follow radiation therapy + Erbitux patient head neck carcinoma almost one measurable lesion RMI CT scan . We hope improve progression free survival 14 % two year .</detailed_description>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>head neck locally advance , non metastatic carcinoma suitable surgery non squamous cell head neck cancer previous malignancy previous treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>induction chemotherapy</keyword>
	<keyword>follow irradiation concurrent Erbitux , radiochemotherapy</keyword>
</DOC>